ALK gene copy number gain and its clinical significance in hepatocellular carcinoma

doi:10.3748/wjg.v20.i1.183

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 1

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5816)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-3) series.

Item

Count

PDF

320

WORD

238

HTML

3471

Figures (1-5)

166

Tables (1-3)

140

Sum=4335

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

737

Download

744

Sum=1481

Jan 7, 2014 (publication date) through Jul 21, 2024

Times Cited of This Article

Times Cited (14)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Jan 7, 2014; 20(1): 183-192
Published online Jan 7, 2014. doi: 10.3748/wjg.v20.i1.183

Full Size Figure Download Figure

Figure 3 Kaplan-Meier survival curves of hepatocellular carcinoma patients classified according to stage stratum. A and B: In the advanced stage stratum ( IIIand IV), overall survival (OS) (A) and progression-free survival (PFS) (B) of hepatocellular carcinoma (HCC) patients with anaplastic lymphoma kinase copy number gain (ALK/CNG)-positivity and ALK/CNG-negativity; C and D: In the early stage stratum (I and II), OS (C) and PFS (D) of HCC patients with ALK/CNG-positivity and ALK/CNG-negativity.

Citation: Jia SW, Fu S, Wang F, Shao Q, Huang HB, Shao JY. ALK gene copy number gain and its clinical significance in hepatocellular carcinoma. World J Gastroenterol 2014; 20(1): 183-192
URL: https://www.wjgnet.com/1007-9327/full/v20/i1/183.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i1.183